CrowdStrike heads into the July 4 holiday week with one of the most unusual options readings of the past year sitting alongside a short-selling picture that is conspicuously calm.
The options market is the story right now. The put/call ratio hit 8.11 on July 2 — the highest level recorded in the past 52 weeks, and more than four standard deviations above its 20-day average of 1.36. Every prior session this month had a PCR running close to 1.0, which makes Thursday's reading a genuine outlier rather than a trend. A ratio that extreme points to either massive protective put buying or a sharp drawdown in call activity — either way, options traders expressed far more defensiveness on that single session than they have at any point in the past year. The stock itself gained 14.3% over the week to close at $193.98, making the defensive options positioning all the more striking against a backdrop of strong price action.
Short interest tells a notably different story, though the data warrants a note of caution. Reported short interest jumped to 28.9 million shares — 11.5% of the free float — on July 2, up roughly fourfold from the 7.5 million shares reported the day before. A move of that magnitude in a single session almost certainly reflects a data revision or a reclassification rather than genuine new short selling, and the longer history shows SI running between 7.2 and 7.7 million shares for the entire prior month. The borrow market corroborates the skepticism: cost to borrow is just 0.36%, down 11% on the week, and availability is enormous at over 5,000% — meaning there are roughly fifty lendable shares for every one currently borrowed. Lenders are not under any pressure whatsoever, and there is no squeeze dynamic in the background.
The Street's view on CRWD is broadly constructive but comes with a meaningful valuation caveat. Most of the post-earnings analyst moves in early June were upward revisions — Citi, UBS, and Jefferies all lifted targets after the Q1 print. The more notable recent action is from Morgan Stanley, which on July 2 adjusted its price target to $172.50 while maintaining an Overweight rating. That target sits below the current price of $193.98, and well below most of the Street consensus. A mean price target near $180 also trails the current price, which is an unusual setup for a name with 94th-percentile forward EPS growth momentum and analyst recommendation scores. The bull case rests on a $10 billion ARR target and a 23% revenue growth trajectory; the bear case points to a P/E near 123x and a price-to-book above 26x, where any slowdown in bookings growth carries real multiple-compression risk. Factor scores are solid — the EPS 12-month forward year-on-year increase ranks in the 94th percentile — but valuation anchors remain stretched by any traditional measure.
Peer context adds texture to the week's setup. Closest correlated peers PANW and RBRK both posted comparable weekly gains of around 18-19%, while TENB surged over 40%, suggesting the cybersecurity sector broadly caught a bid this week. CRWD's 14% gain kept pace with the peer group but did not stand out as exceptional, meaning the move reflects sector rotation as much as stock-specific momentum.
The next scheduled catalyst is the August 25 earnings release, the last print before which showed a 6.5% single-day drop and a 16% slide over the following five days after the June 3 result. That reaction pattern — and the anomalous options spike this week — are the two gauges worth tracking as the stock approaches its next quarterly test.
See the live data behind this article on ORTEX.
Open CRWD on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
